Hi Friends

Greetings from Hari.

Marlabs Inc. is a leading medical informatics company with strong presence and
proven track record in the medical / healthcare area. We have implemented
several prestigious applications for clinical and pre-clinical trials for some
of the reputed clients the US. Marlabs features in Deloitte & Touche`s
prestigious "Technology Fast 50" Program for New Jersey, a ranking of the 50
fastest growing technology companies in the area. Marlabs` growth in revenues of
1,367 percent from 1997 to 2001 resulted in an overall ranking of 151 in the
2002 INC 500 - a ranking of the fastest growing companies in the US. Please
visit http://www.marlabs.com to know mroe about us.

We are currently looking for experienced SAS programmers in clinical trial on
fulltime arrangement. Should have experience in Data modeling, Data Analysis,
Data extraction and Data Exploration using SAS tools. Work permit (H1B) will be
sponsored for eligible people outside the US. Preference will be given to those
who are SAS or Brainbech certified professionals. Marlabs provides excellent
salary benefits ,relocation allowance, holiday plans, medical insurance apart
from a range of other packages.

SKILL SET

General:
The candidate must have SAS experience in a Clinical Trial set up for 2-3 years.
Must have strong experience with Unix/VMS/Windows Operating systems.

Data Warehousing & Mining: SAS ver 8.0, SAS ver 8.2, SAS ver 6.12 (Base, AF/SCL,
ODS, STAT, FSP, Graph, SQL, OR, QC, ETS, Macros, Access, Assist, Insight,
Connect, Share, Internet, Oracle Clinical, Warehouse Administrator etc.,),

OLAP/EIS Tools: SAS/EIS, SAS/MDDB Server, SAS/AppDev, Business Objects

Desired skills:
Database and Front End GUI tools.


If you match the above requirement, please send your resume to hari@...
with subject as "SAS" .

Regards

Hari

_______________________________

P.K.Haridas
Manager - India Operations
Marlabs Inc.
Phone +91-80-5092113,5321582 and 83

http://india.marlabs.com
http://www.marlabs.com

Your IT Partner in Success


[Non-text portions of this message have been removed]